|MDACC Study No:||2013-0590 (clinicaltrials.gov NCT No: NCT02010645)|
|Title:||Phase II Study of Eltrombopag in Combination with Decitabine in Subjects with Advanced Myelodysplastic Syndrome|
|Principal Investigator:||Courtney DiNardo|
|Treatment Agent:||Decitabine; Eltrombopag |
|Study Description:||The goal of this clinical research study is to learn if eltrombopag given in |
combination with decitabine can help to control advanced MDS. The safety of
this study drug combination will also be studied.